Prognostic significance of expression patterns of egfr family, p21 and p27 in high-grade astrocytoma

Hiroshima Journal of Medical Sciences

Volumn 59, Issue 4, 2010, Pages 65-70

  Nabika, Shinya ^a   Kiya, Katsuzo ^a   Satoh, Hideki ^a   Mizoue, Tatsuya ^a   Kondo, Hiroshi ^a   Katagiri, Masaya ^a   Nishisaka, Takashi ^a   Sugiyama, Kazuhiko ^b   Kurisu, Kaoru ^b  

^a HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

EGFR; High grade astrocytoma; p21; p27

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P21; PROTEIN P27; CDKN1A PROTEIN, HUMAN; CDKN1B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR 4; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; BREAST TUMOR; CHEMISTRY; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79952563517     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Andersson, U., Guo, D., Maimer, B., Bergenheim, A.T., Brannstrom, T., Hedman, H. and Henriksson, R. 2004. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol. (Berl) 108: 135-142. (Pubitemid 39136299)
2. Bal, M.M., Das, R.B., Srinivasan, R. and Sharma, S.C. 2006. Expression of c-erbB-4 in medulloblastoma and its correlation with prognosis. Histopathology 49: 92-93. (Pubitemid 43972927)
3. Etienne, M.C., Formento, J.L., Lebrun-Frenay, C., Gioanni, J., Chatel, M., Paquis, P., Bernard, C., Courdi, A., Bensadoun, R.J., Piqnol, J.P., Francoual, M., Grellier, P., Frenay, M. and Milano, G. 1998. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin. Cancer Res. 4: 2383-2390.
4. Graber, H.U., Friess, H., Kaufmann, B., Willi, D., Zimmermann, A., Korc, M. and Buchler, M.W. 1999. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer. Int. J. Cancer 84: 24-27. (Pubitemid 29059103)
5. Heimberger, A.B., Hlatky, R., Suki, D., Yang, D., Weinberg, J., Gilbert, M., Sawaya, R. and Aldape, K. 2005. Prognostic effect of epidermal growth factor receptor and EGFR vIII in glioblastoma multiforme patients. Clin. Cancer Res. 11: 1462-1466.
6. Kataoka, H., Joh, T., Kasugai, K., Okayama, N., Moriyama, A., Asai, K. and Kato, T. 1998. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa. Life Sci. 63: 553-564. (Pubitemid 28355818)
7. Kew, T.Y., Bell, J.A., Pinder, S.E., Denley, H., Srinivasan, R., Gullick, W.J., Nicholson, R.I., Blarney, R.W. and Ellis, I.O. 2000. c-erbB-4 protein expression in human breast cancer. Br. J. Cancer 82: 1163-1170. (Pubitemid 30128873)
8. Kirla, R.M., Haapasalo, H.K., Kalimo, H. and Salminen, E.K. 2003. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 97: 644-648. (Pubitemid 36125841)
9. Kirla, R.M., Haapasalo, H.K., Kalimo, H. and Salminen, E.K. 2000. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. J. Neurooncol. 46: 71-80.
10. Koka, V., Potti, A., Forseen, S.E., Pervez, H., Fraiman, G.N., Koch, M. and Levitt, R. 2003. Role of Her-2/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme. Am. J. Clin. Oncol. 26: 332-335.
11. Korkolopoulou, P., Christodoulou, P., Kouzelis, K., Hadjiyannakis, M., Priftis, A., Stamoulis, G., Seretis, A. and Thomas-Tsagli, E. 1997. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br. J. Cancer 75: 1269-1278. (Pubitemid 27179815)
12. Korshunov, A., Golanov, A., Sycheva, R. and Pronin, I. 1999. Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J. Clin. Pathol. 52: 574-580.
13. Kristt, D.A. and Yarden, Y. 1996. Differences between phosphotyrosine accumulation and neu/erbB-2 receptor expression in astrocytic proliferative processes: implication for glial oncogenesis. Cancer 78: 1272-1283. (Pubitemid 26303895)
14. Lee, J.C., Wang, S.T., Chow, N.H. and Yang, H.B. 2002. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery. Eur. J. Cancer 38: 1065-1071. (Pubitemid 34468011)
15. Lyne, J.C., Melhem, M.F., Finley, G.G., Wen, D., Liu, N., Deng, D.H. and Salup, R. 1997. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Cancer J. Sci. Am. 3: 21-30.
16. Nishikawa, R., Furnari, F.B., Lin, H., Arap, W., Berger, M.S., Cavenee, W.K. and Su, Huang, H.J. 1995. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res. 55:1941-1945.
17. Potti, A., Forseen, S.E., Koka, V.K., Pervez, H., Koch, M., Fraiman, G., Mehdi, S.A. and Levitt, R. 2004. Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors. Cancer Invest. 22: 537-544. (Pubitemid 39506874)
18. Rainov, N.G., Dobberstein, K.U., Bahn, H., Holzhausen, H. J., Lautenschlager, C., Heidecke, V. and Burkert, W. 1997. Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J. Neurooncol. 35: 13-28. (Pubitemid 27361842)
19. Shinojima, N., Tada, K., Shiraishi, S., Kamiryo, T., Kochi, M., Nakamura, H., Makino, K., Saya, H., Hirano, H., Kuratsu, J., Oka, K., Ishimaru, Y. and Ushio, Y. 2003. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res. 63: 6962-6970. (Pubitemid 37322983)
20. Simmons, M.L., Lamborn, K.R., Takahashi, M., Chen, P., Israel, M.A., Berger, M.S., Godfrey, T., Nigro, J., Prados, M., Chang, S., Barker, F.G. 2nd and Aldape, K. 2001. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 61: 1122-1128.
21. Smith, J.S., Tachibana, I., Passe, S.M., Huntley, B.K., Borell, T.J., Iturria, N., O'Fallon, J.R., Schaefer, P.L., Scheithauer, B.W., James, C.D., Buchner, J.C. and Jenkins, R.B. 2001. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J. Natl. Cancer Inst. 93: 1246-1256.
22. Thomasson, M., Hedman, H., Junttila, T.T., Elenius, K., Ljungberg, B. and Henriksson, R. 2004. ErbB4 is downregulated in renal cell carcinoma-a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family. Acta Oncol. 43: 453-459. (Pubitemid 39037093)
23. Yarden, Y. and Sliwkowsky, M.X. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2: 127-137.